Hashim Al-Ani to Cardiomyopathy, Hypertrophic
This is a "connection" page, showing publications Hashim Al-Ani has written about Cardiomyopathy, Hypertrophic.
Connection Strength
0.216
-
Ismail MF, Obeidat O, Abughazaleh S, Daise MA, Alqudah Q, Tarawneh M, Alzghoul H, Al-Ani H, Iqbal J, Ismail K. Temporal trends, prevalence, predictors, and outcomes of heart failure in patients with hypertrophic cardiomyopathy in the United States: Insights from the national inpatient sample. Curr Probl Cardiol. 2024 Aug; 49(8):102665.
Score: 0.111
-
Bishev D, Fabara S, Loseke I, Alok A, Al-Ani H, Bazikian Y. Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review. Heart Lung Circ. 2023 Sep; 32(9):1049-1056.
Score: 0.105